Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results

Erqi L. Pollom, Dylann Fujimoto, Jacob Wynne, Kira Seiger, Leslie A. Modlin, Lisa R. Jacobs, Melissa Azoulay, Rie von Eyben, Laurie Tupper, Iris C. Gibbs, Steven L. Hancock, Gordon Li, Steven D. Chang, John R. Adler, Griffith R. Harsh, Ciara Harraher, Seema Nagpal, Reena P. Thomas, Lawrence D. Recht, Clara Y.H. ChoiScott G. Soltys

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy